These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 34084195)

  • 21. Genetics and the metabolic syndrome.
    Fanning E; O'Shea D
    Clin Dermatol; 2018; 36(1):9-13. PubMed ID: 29241759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): results of a large database from a specialist Endocrine Clinic.
    Wijeyaratne CN; Seneviratne Rde A; Dahanayake S; Kumarapeli V; Palipane E; Kuruppu N; Yapa C; Seneviratne Rde A; Balen AH
    Hum Reprod; 2011 Jan; 26(1):202-13. PubMed ID: 21098627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dermatology of androgen-related disorders.
    Essah PA; Wickham EP; Nunley JR; Nestler JE
    Clin Dermatol; 2006; 24(4):289-98. PubMed ID: 16828411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic implications of dermoscopic findings in acanthosis nigricans: A clinical and histopathological study.
    Pardeshi SS; Khemani UN; Kamath RR; Kura MM; Jafferany M
    Dermatol Ther; 2020 Nov; 33(6):e14521. PubMed ID: 33176058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents.
    Masquio DC; de Piano A; Campos RM; Sanches PL; Carnier J; Corgosinho FC; Netto BD; Carvalho-Ferreira JP; Oyama LM; Nascimento CM; de Mello MT; Tufik S; Dâmaso AR
    Br J Nutr; 2015 Jun; 113(12):1920-30. PubMed ID: 25907896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dermatologic manifestations of polycystic ovary syndrome.
    Lee AT; Zane LT
    Am J Clin Dermatol; 2007; 8(4):201-19. PubMed ID: 17645376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polycystic ovary syndrome: a dermatologic approach.
    Moura HH; Costa DL; Bagatin E; Sodré CT; Manela-Azulay M
    An Bras Dermatol; 2011; 86(1):111-9. PubMed ID: 21437531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acanthosis nigricans associated with insulin resistance : pathophysiology and management.
    Hermanns-Lê T; Scheen A; Piérard GE
    Am J Clin Dermatol; 2004; 5(3):199-203. PubMed ID: 15186199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Woman 19-old with hirsutism, obesity and acanthosis nigricans].
    Kępczyńska-Nyk A; Muszel M; Radziszewski M; Wocial K
    Pol Merkur Lekarski; 2016 Sep; 41(243):141-144. PubMed ID: 27755516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dermatologic Manifestations of Endocrine Disorders.
    Raj R; Elshimy G; Mishra R; Jha N; Joseph V; Bratman R; Tella SH; Correa R
    Cureus; 2021 Sep; 13(9):e18327. PubMed ID: 34692360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dermatologic manifestations of endocrine disorders.
    Quatrano NA; Loechner KJ
    Curr Opin Pediatr; 2012 Aug; 24(4):487-93. PubMed ID: 22781138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acanthosis nigricans, insulin resistance and cutaneous virilism.
    Barth JH; Ng LL; Wojnarowska F; Dawber RP
    Br J Dermatol; 1988 May; 118(5):613-9. PubMed ID: 3293647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acne-associated syndromes: models for better understanding of acne pathogenesis.
    Chen W; Obermayer-Pietsch B; Hong JB; Melnik BC; Yamasaki O; Dessinioti C; Ju Q; Liakou AI; Al-Khuzaei S; Katsambas A; Ring J; Zouboulis CC
    J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):637-46. PubMed ID: 21198949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polycystic ovary syndrome: a review for dermatologists: Part I. Diagnosis and manifestations.
    Housman E; Reynolds RV
    J Am Acad Dermatol; 2014 Nov; 71(5):847.e1-847.e10; quiz 857-8. PubMed ID: 25437977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Association of Various Metabolic Parameters with Multiple Skin Tags.
    Platsidaki E; Vasalou V; Gerodimou M; Markantoni V; Kouris A; Vryzaki E; Gregoriou S; Rigopoulos D; Kontochristopoulos G
    J Clin Aesthet Dermatol; 2018 Oct; 11(10):40-43. PubMed ID: 30519379
    [No Abstract]   [Full Text] [Related]  

  • 36. Thiazolidinediones for the therapeutic management of polycystic ovary syndrome : impact on metabolic and reproductive abnormalities.
    Elkind-Hirsch KE
    Treat Endocrinol; 2006; 5(3):171-87. PubMed ID: 16677059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Obese children with benign acanthosis nigricans and insulin resistance: analysis of 19 cases].
    Fu JF; Liang L; Dong GP; Jiang YJ; Zou CC
    Zhonghua Er Ke Za Zhi; 2004 Dec; 42(12):917-9. PubMed ID: 15733362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Familial acanthosis nigricans. A longitudinal study.
    Friedman CI; Richards S; Kim MH
    J Reprod Med; 1987 Jul; 32(7):531-6. PubMed ID: 3305929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting inflammation in metabolic syndrome.
    Welty FK; Alfaddagh A; Elajami TK
    Transl Res; 2016 Jan; 167(1):257-80. PubMed ID: 26207884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic syndrome and cardiometabolic risk factors among indigenous Malaysians.
    Aghakhanian F; Wong C; Tan JSY; Yeo LF; Ramadas A; Edo J; Hoh BP; Khalid BAK; Phipps ME
    Public Health; 2019 Nov; 176():106-113. PubMed ID: 30509859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.